RecruitingNot ApplicableNCT07313566

R³ Rehab Pathway Versus Usual Care After Lumbar Radicular Surgery

An Evidence-based Rehabilitation Pathway for Patients Undergoing Surgery for Lumbar Radicular Pain to Promote Return to Work: a Cluster Randomized Trial Comparison With Usual Care.


Sponsor

Universitaire Ziekenhuizen KU Leuven

Enrollment

480 participants

Start Date

Mar 16, 2026

Study Type

INTERVENTIONAL

Conditions

Summary

The R³ trial is a multicentre cluster randomized controlled trial evaluating an evidence-based, person-centred rehabilitation pathway for patients undergoing lumbar surgery for radicular pain. The pathway includes structured pre-, peri-, and postoperative rehabilitation, early postoperative mobilization, case management, early return-to-work (RTW) guidance, and patient empowerment. Clusters (hospitals) are randomized to implement the R³ pathway (intervention) or continue usual care (control). The primary aim is to determine whether the R³ pathway reduces time to return to work compared with usual care.


Eligibility

Min Age: 18 YearsMax Age: 65 Years

Plain Language Summary

Simplified for easier understanding

This clinical trial is studying R³ Rehabilitation Pathway for people with lumbar radiculopathy and radicular low back pain. The study is currently recruiting participants at 16 locations. People eligible for this study include aged 18 Years to 65 Years.

This summary was AI-generated to explain the trial in plain language. It is not medical advice. Always discuss eligibility with your doctor before enrolling in a clinical trial.

Interested in this trial?

Get notified about updates and connect with the research team.

Interventions

OTHERR³ Rehabilitation Pathway

A structured evidence-based rehabilitation pathway, guided by a case manager, starting preoperatively to 1 year postoperatively, including prehabilitation, perioperative rehabilitation and postoperative rehabilitation, with emphasis on fear reduction by keeping activity restrictions minimal and relevant, eliminating bracing and on active guidance to work resumption.


Locations(16)

ZAS

Antwerp, Belgium

AZ Sint Jan Brugge

Bruges, Belgium

UZ Brussel

Brussels, Belgium

Grand Hôpital de Charleroi

Charleroi, Belgium

Ziekenhuis Geel

Geel, Belgium

ZOL Genk

Genk, Belgium

Jessa Ziekenhuis

Hasselt, Belgium

AZ Herentals

Herentals, Belgium

Jan Yperman ziekenhuis

Ieper, Belgium

AZ Groeninge Kortrijk

Kortrijk, Belgium

UZ Leuven

Leuven, Belgium

Heilig Hart Lier

Lier, Belgium

AZ Sint Maarten Mechelen

Mechelen, Belgium

CSPO

Ottignies, Belgium

AZ Delta Roeselare

Roeselare, Belgium

Centre Hospitalier de Wallonie Picarde

Tournai, Belgium

View Full Details on ClinicalTrials.gov

For the most up-to-date information, visit the official listing.

Visit

NCT07313566


Related Trials